Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Drug Makers, Professors Ask Justices to Review Merck Patent Loss

Nov. 17, 2020, 10:46 PM

An attempt by Merck & Co.’s Idenix to salvage a record $2.5 billion patent verdict at the U.S. Supreme Court has gotten the backing of two major drug companies and more than a dozen intellectual property professors.

Idenix asked the justices in late September to review a decision from the U.S. Court of Appeals for the Federal Circuit finding its patent on a hepatitis C treatment is invalid. The Federal Circuit affirmed a trial court ruling that negated the $2.5 billion verdict against Gilead Sciences Inc. It was the largest patent verdict in U.S. history.

The IP professors ...